Thero2-01S22
N/A
Report date: 2023/01/28 20:00:33
Base Information
Drug NameThero2-01S22
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesInstitut De Cancerologie Strasbourg Europe
China Registration ClassN/A
Develop Information
Active CompaniesInstitut De Cancerologie Strasbourg Europe
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A